Kyowa Kirin is investing $530 million into a 171,700 square-foot manufacturing facility in Sanford, North Carolina, which will make biologic therapies, including antibodies, for clinical …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Belgium drugmaker Argenx said Tuesday that its antibody medicine failed to achieve the goals of a late-stage study for a platelet-destroying autoimmune disorder — a
Jakob Uszkoreit, one of the people who laid the groundwork for generative platforms such as ChatGPT, has secured $100 million in a Series A raise
The Centers for Disease Control and Prevention issued a new risk assessment of the H5N1 bird flu virus circulating in dairy cows on Friday, increasing